Soleno Therapeutics (SLNO) Reports Strong Q3 Earnings Despite VYKAT XR Safety Concerns
Yahoo Finance· 2025-11-25 21:39
Soleno Therapeutics, Inc. (NASDAQ:SLNO) ranks among the most oversold biotech stocks to invest in. Soleno Therapeutics, Inc. (NASDAQ:SLNO) reported third-quarter adjusted earnings of $0.47 per share on November 4, significantly exceeding analyst projections of $0.05 per share. Revenue also came in significantly higher than the consensus expectations at $66 million. Despite the strong results, the company’s stocks tumbled that day. Investor concerns regarding discontinuation rates for VYKAT XR, the compan ...
Novavax Shifts From COVID Sales to R&D Focus While Updating 2025 Forecast
Yahoo Finance· 2025-11-25 21:39
Novavax, Inc. (NASDAQ:NVAX) ranks among the most oversold biotech stocks to invest in. Novavax, Inc. (NASDAQ:NVAX) announced its third-quarter 2025 financial results on November 6, emphasizing the company’s continuous strategic shift from a direct COVID-19 commercial operation to an R&D-focused company, especially in partnership with Sanofi. For the third quarter, Novavax, Inc. (NASDAQ:NVAX) reported total revenue of $70 million, an 18% drop from $85 million during the same period the previous year. Mean ...
Oppenheimer Reaffirms Outlook on CRISPR Therapeutics (CRSP) After Encouraging Q3 Earnings Performance
Yahoo Finance· 2025-11-25 21:39
CRISPR Therapeutics AG (NASDAQ:CRSP) ranks among the most oversold biotech stocks to invest in. Following the company’s third-quarter financial results, Oppenheimer reaffirmed its Outperform rating and $95 price target for CRISPR Therapeutics AG (NASDAQ:CRSP) on November 11. CRISPR Therapeutics AG (NASDAQ:CRSP) reported a lower-than-anticipated loss of $1.17 per share against the expected $1.26 per share, largely due to reduced R&D spending of $59 million compared to the expected $88 million. Pixabay/Pub ...
What Makes Avient Corp (AVNT) a Lucrative Investment?
Yahoo Finance· 2025-11-25 21:38
Cullen Capital Management, LLC, operating under the name Schafer Cullen Capital Management, Inc. (SCCM), has released its “SCCM Small Cap Value Equity Strategy” third-quarter investor letter. A copy of the letter can be downloaded here. The US equity market continued the rally in the third quarter, with the Russell 2000 returning 12.4% and the Russell 2000 Value surging 12.6%. The Small Cap Value Equity strategy returned 14.4% (gross of fees) and 14.2% (net of fees) in the quarter. The small caps delivered ...
US retail sales miss expectations in September
Reuters· 2025-11-25 21:38
U.S. retail sales increased less than expected in September, taking a breather following a recent stretch of strong gains. ...
Is UnitedHealth Group (UNH) The Best Non-Tech Stock to Buy? Reddit Says Yes
Yahoo Finance· 2025-11-25 21:38
We recently published Top 10 Non-AI Stocks Redditors are Buying Ahead of Potential Bubble Burst. UnitedHealth Group Inc (NYSE:UNH) is one of the top non-AI stocks redditors are buying. UnitedHealth Group Inc (NYSE:UNH) is one of the best non-tech and non-AI stocks to buy according to Redditors. The stock is down 35% so far this year, but Redditors believe the insurance giant will rally in the long term. As of the end of the third quarter, Warren Buffett’s Berkshire Hathaway owns about 5 million shares of ...
I Think Gap (GAP) “Turns Out to be the Winner,” Says Jim Cramer
Yahoo Finance· 2025-11-25 21:38
We recently published Jim Cramer Discussed These 11 Stocks & Commented On A Market Reversal. The Gap, Inc. (NYSE:GAP) is one of the stocks Jim Cramer discussed. Apparel retailer The Gap, Inc. (NYSE:GAP) is currently in the middle of a tough turnaround through which it is consolidating its brands and cutting down costs. Cramer has discussed the efforts several times in his morning appearances and expressed optimism about the firm's CEO in most of these. The Gap, Inc. (NYSE:GAP) reported its fiscal third q ...
INVESTOR REMINDER: Important CarMax, Inc. Securities Class Action Deadline Approaching on January 2 for Investors with Losses – Contact BFA Law
Globenewswire· 2025-11-25 21:38
NEW YORK, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against CarMax, Inc. (NYSE: KMX) and certain of the Company’s senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws. If you invested in CarMax, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/carmax-inc-class-action-lawsuit. In ...
Novo Nordisk’s Longshot Alzheimer's Trial Didn’t Work, But It Is Still Worth Buying (NVO)
Seeking Alpha· 2025-11-25 21:37
The Danish pharmaceutical giant Novo Nordisk A/S ( NVO ) published news on Monday that its Evoke and Evoke+ phase 3 trials using oral semaglutide (Wegovy/Ozempic) as a potential treatment for Alzheimer’s Disease "did not demonstrate a statisticallyI have been investing in the stock market since I was 17 years old, and over the 25+ years since I have learned the joy of compounding, the value of dividend reinvesting, and the principle that patient investing through good times and bad brings the greatest rewar ...
Consumer Confidence Dives, Employment Falls, Supporting Fed Cut
Investors· 2025-11-26 00:49
宏观经济数据与市场情绪 - 9月零售销售和生产者价格指数(PPI)数据将于美东时间上午8:30公布,为美联储12月10日的政策更新提供参考[1] - ADP新的周度就业增长报告显示私营部门薪资下滑,该报告旨在填补政府停摆造成的数据空白[1] - 标准普尔500指数期货基本持平,市场反弹面临关键考验[1][2] 人工智能芯片行业动态 - 谷歌正洽谈向Meta提供其人工智能芯片,此消息导致英伟达和AMD股价下跌[1][4] - 人工智能股票面临“证明给我看”的时刻,市场担忧人工智能泡沫,并列出五个值得担忧的理由[4] - 随着英伟达等人工智能股票失色,有公司被视为有望发光的宝石[4] 重点公司表现与市场关注 - 字母表公司股价创下新高,在“七巨头”中表现领先[4] - 华尔街权衡新的人工智能股票担忧,认为谷歌的胜利可能是一个需要关注的风险[4] - 专业交易员认为亚马逊是新科技时代的最佳投资选择[4]